ANMI Trademark

Trademark Overview


On Wednesday, August 26, 2020, a trademark application was filed for ANMI with the United States Patent and Trademark Office. The USPTO has given the ANMI trademark a serial number of 79297420. The federal status of this trademark filing is REGISTERED as of Tuesday, June 1, 2021. This trademark is owned by Telix Pharmaceuticals Limited. The ANMI trademark is filed in the Pharmaceutical Products, Medical Instrument Products, and Computer & Software Services & Scientific Services categories with the following description:

Scientific research; scientific research in the field of pharmacy; research on the subject of pharmaceuticals; medical research; research and development of products; providing scientific advisory services relating to immunological products; provision of scientific information in the fields of biochemistry, biotechnology and clinical trials; scientific consultancy, namely, consulting services in the fields of biotechnology, pharmaceutical research and development, and genetic science all of the aforementioned in relation to radiopharmaceuticals and cancer

Chemical preparations for pharmaceutical purposes, namely, diagnostic radiopharmaceutical preparations; pharmaceutical preparations for the imaging, diagnosing and monitoring of cancer; pharmaceutical preparations for the treatment of cancer; radiopharmaceutical imaging and detection agents for use in the imaging, diagnosing and monitoring of cancer

Medical apparatus, namely, infusion and injection devices sold empty for administering drugs and diagnostic radiopharmaceuticals, namely, syringes; apparatus for medical purposes, namely, drug delivery devices sold empty for diagnostic radiopharmaceuticals, namely, syringes; medical devices for treating cancer; diagnostic imaging apparatus for medical use
anmi

General Information


Serial Number79297420
Word MarkANMI
Filing DateWednesday, August 26, 2020
Status700 - REGISTERED
Status DateTuesday, June 1, 2021
Registration Number6367058
Registration DateTuesday, June 1, 2021
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, March 16, 2021

Trademark Statements


Goods and ServicesScientific research; scientific research in the field of pharmacy; research on the subject of pharmaceuticals; medical research; research and development of products; providing scientific advisory services relating to immunological products; provision of scientific information in the fields of biochemistry, biotechnology and clinical trials; scientific consultancy, namely, consulting services in the fields of biotechnology, pharmaceutical research and development, and genetic science all of the aforementioned in relation to radiopharmaceuticals and cancer
Goods and ServicesChemical preparations for pharmaceutical purposes, namely, diagnostic radiopharmaceutical preparations; pharmaceutical preparations for the imaging, diagnosing and monitoring of cancer; pharmaceutical preparations for the treatment of cancer; radiopharmaceutical imaging and detection agents for use in the imaging, diagnosing and monitoring of cancer
Goods and ServicesMedical apparatus, namely, infusion and injection devices sold empty for administering drugs and diagnostic radiopharmaceuticals, namely, syringes; apparatus for medical purposes, namely, drug delivery devices sold empty for diagnostic radiopharmaceuticals, namely, syringes; medical devices for treating cancer; diagnostic imaging apparatus for medical use

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateWednesday, December 30, 2020
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

International Class010 - Surgical, medical, dental, and veterinary apparatus and instruments, artificial limbs, eyes, and teeth; orthopedic articles; suture materials.
US Class Codes026, 039, 044
Class Status Code6 - Active
Class Status DateWednesday, December 30, 2020
Primary Code010
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateWednesday, December 30, 2020
Primary Code042
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameTelix Pharmaceuticals Limited
Party Type30 - Original Registrant
Legal Entity Type99 - Other
AddressAU

Party NameTelix Pharmaceuticals Limited
Party Type20 - Owner at Publication
Legal Entity Type99 - Other
AddressAU

Party NameTelix Pharmaceuticals Limited
Party Type10 - Original Applicant
Legal Entity Type99 - Other
AddressAU

Trademark Events


Event DateEvent Description
Thursday, November 5, 2020SN ASSIGNED FOR SECT 66A APPL FROM IB
Monday, December 28, 2020LIMITATION FROM ORIGINAL APPLICATION ENTERED
Wednesday, December 30, 2020NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Wednesday, December 30, 2020ASSIGNED TO EXAMINER
Monday, January 4, 2021NON-FINAL ACTION WRITTEN
Tuesday, January 5, 2021APPLICATION FILING RECEIPT MAILED
Tuesday, January 5, 2021NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Monday, January 25, 2021REFUSAL PROCESSED BY MPU
Monday, January 25, 2021NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Tuesday, February 9, 2021TEAS RESPONSE TO OFFICE ACTION RECEIVED
Tuesday, February 9, 2021CORRESPONDENCE RECEIVED IN LAW OFFICE
Tuesday, February 9, 2021TEAS/EMAIL CORRESPONDENCE ENTERED
Tuesday, February 9, 2021APPROVED FOR PUB - PRINCIPAL REGISTER
Sunday, February 14, 2021REFUSAL PROCESSED BY IB
Wednesday, February 24, 2021NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Wednesday, February 24, 2021NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
Wednesday, February 24, 2021NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Monday, March 15, 2021NOTIFICATION PROCESSED BY IB
Tuesday, March 16, 2021PUBLISHED FOR OPPOSITION
Tuesday, March 16, 2021OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, June 1, 2021REGISTERED-PRINCIPAL REGISTER
Wednesday, September 1, 2021FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Thursday, September 23, 2021FINAL DISPOSITION PROCESSED
Thursday, September 23, 2021FINAL DISPOSITION NOTICE SENT TO IB
Monday, October 25, 2021FINAL DECISION TRANSACTION PROCESSED BY IB
Sunday, August 14, 2022NEW REPRESENTATIVE AT IB RECEIVED
Thursday, February 26, 2026NEW REPRESENTATIVE AT IB RECEIVED